Open Slide Modal

Innovation on a Mission

Visionary startups. Experienced VCs. Dedicated government professionals. In-Q-Tel leads from the center of this matrix, connecting cutting-edge technology, strategic investments, and purpose: to enhance and advance national security for the U.S. and its allies.

World-class, cutting-edge technologies for National Security

In-Q-Tel scouts the global market for cutting-edge technologies that have both high national security impact and the potential for commercial success. Investment areas include:

Recipe Image

Digital Intelligence

Recipe Image

Trusted Infrastructure

Recipe Image

Autonomous Systems

Recipe Image

Industry 4.0

Recipe Image

Intelligent Connectivity

Recipe Image

Data Analytics

Recipe Image

AI and Machine Learning

Recipe Image

IT Platforms

Featured Investments

Dreamscape Immersive

QuintessenceLabs

Red Sift

Tamr

Emesent

Markforged

Deepgram

Lilt

Blog & Resources

The Holodeck & The Future of History

Star Trek’s holodeck has long inspired dreams of digitizing our world into interactive, immersive, playable 3D space. Spatial computing is […]

The Teachable Camera Hardware

From Redux to Apollo Cache: What to Consider When Making the Switch

Take the Pain out of Orchestrating & Instrumenting Testbed Environments with Portunus

SpaceNet 7 Results: ‘Tis the Season

Subscribe

January 19, 2021

Getting Back to Work and School:  Enhancing Access to COVID-19 Testing

In the era of COVID-19, how do we create safe environments for people to return to work, school, and their daily lives? B.Next’s Dr. Kevin O’Connell is joined by Troy Moore, Chief Scientific Officer and Founder at Kailos Genetics, an In-Q-Tel portfolio company providing cost-effective solutions that make genetic screening accessible to everyone. Listen in as the two explore the importance and impact of testing, genetic sequencing, the company’s capture and enrichment methodology adapted to work with the COVID-19 virus, and more.

 

January 12, 2021

Synthetic Biology:  A Core Capability for Biosecurity

B.Next’s Dr. Kevin O’Connell is joined by Jason Kelly, Founder of Ginkgo Bioworks, an In-Q-Tel portfolio company using the most advanced technology on the planet—biology—to grow better products. Learn more about their platform that programs cells, and how they leverage this capability to expand biosecurity and pandemic response.

Learn more at ginkgobioworks.com.